BRCA1 and breast cancer: The cumulative risk of developing breast cancer (BC) to the age of 80 years for heterozygotes of BRCA1 and BRCA2 pathogenic variants (hereafter, heterozygotes), has been approximated at 72% (95% CI 65–79%) and 69% (95% CI 61–77%), respectively.